Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Human Genetics

• Publication date

  2012-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ejhg.2012.124PMID 22763381PMCID PMC3548269
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ingredients for success: a familial cancer clinic in an oncology practice setting.

  2011cited by this paper
• The impact of Converso Jews on the genomes of modern Latin Americans

  2011cited by this paper
• Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

  2011cited by this paper
• On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations

  2011cited by this paper
• Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry.

  2010cited by this paper
• Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection

  2010cited by this paper
• Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

  2009cited by this paper
• The Genetic Legacy of Religious Diversity and Intolerance: Paternal Lineages of Christians, Jews, and Muslims in the Iberian Peninsula

  2008cited by this paper
• Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

  2008cited by this paper
• Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

  2008cited by this paper
• Independent origin of 185delAG BRCA1 mutation in an Indian family.

  2007cited by this paper
• The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies

  2007cited by this paper
• To the End of the Earth: A History of the Crypto-Jews of New Mexico

  2006cited by this paper
• Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.

  2006cited by this paper
• Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

  2006cited by this paper
• High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

  2006cited by this paper
• Breast cancer predisposing alleles in Poland

  2005cited by this paper
• Prevalence of BRCA Mutations and Founder Effect in High-Risk Hispanic Families

  2005cited by this paper
• BRCA1:185delAG found in the San Luis Valley probably originated in a Jewish founder

  2005cited by this paper
• The Norwegian founder mutations in BRCA1: high penetrance confirmed in an incident cancer series and differences observed in the risk of ovarian cancer.

  2003cited by this paper
• Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado

  2003cited by this paper
• A high-resolution recombination map of the human genome

  2002cited by this paper
• Germline BRCA1 Mutation Analysis in Indian Breast/Ovarian Cancer Families

  2002cited by this paper
• Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins

  2002cited by this paper
• A genetic profile of contemporary Jewish populations

  2001cited by this paper
• Estimate of the mutation rate per nucleotide in humans.

  2000cited by this paper
• Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non‐Ashkenazi Jewish women with familial breast and ovarian cancer

  2000cited by this paper
• An update on DNA-based BRCA1/BRCA2 genetic counseling in hereditary breast cancer.

  1999cited by this paper
• Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients

  1999cited by this paper
• Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

  1999cited by this paper
• The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.

  1998cited by this paper
• Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

  1998cited by this paper
• Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

  1998cited by this paper
• Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population

  1998cited by this paper
• The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

  1997cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.

  1996cited by this paper
• Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

  1996cited by this paper
• Mutation of human short tandem repeats.

  1993cited by this paper
• The Secret Jews

  1973cited by this paper

• Genetic screening of FFPE breast cancer biopsies for the BRCA1-185delAG mutation in Trinidad and Tobago

  2025cites this paper
• The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians

  2024cites this paper
• BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer

  2024cites this paper
• Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

  2023cites this paper
• Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling

  2023cites this paper
• Distinct landscapes of deleterious variants in DNA damage repair system in ethnic human populations

  2022cites this paper
• Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations

  2022cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• Ethnic‐specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population

  2022influential citation
• Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine

  2022cites this paper
• Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast Cancer

  2022cites this paper
• Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14th century

  2022cites this paper
• Chasing the origin of 23 recurrent BRCA1 mutations in Pakistani breast and ovarian cancer patients

  2022cites this paper
• Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants

  2022cites this paper
• The reduction of two BRCA1 gene mutations frequencies in ovarian cancer patients from Ukraine

  2021cites this paper
• Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India

  2021cites this paper
• Discovery of BRCA1/BRCA2 founder variants by haplotype analysis.

  2021cites this paper
• DNA damage repair system in C57BL/6 J mice is evolutionarily stable

  2021cites this paper
• Ethnic-specific BRCA1/2 variation within Asia population: evidence from over 78 000 cancer and 40 000 non-cancer cases of Indian, Chinese, Korean and Japanese populations

  2020cites this paper
• Convolutional Embedded Networks for Population Scale Clustering and Bio-Ancestry Inferencing

  2020cites this paper
• Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors

  2020cites this paper
• Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer?

  2020cites this paper
• The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

  2019cites this paper
• BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry

  2019cites this paper
• Human Mutation

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• BRCA mutations in a cohort of Iraqi patients presenting to a tertiary referral center

  2019cites this paper
• Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations

  2018cites this paper
• Big Genome Data Classification with Random Forests Using VariantSpark

  2018cites this paper
• Recurrent Deep Embedding Networks for Genotype Clustering and Ethnicity Prediction

  2018cites this paper
• Convolutional Embedded Networks for Population Scale Clustering and Bio-ancestry Inferencing.

  2018cites this paper
• Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India

  2018influential citation
• Mutational analysis of candidate genes in Israeli male breast cancer cases

  2018cites this paper
• University of Birmingham Heterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India

  2018influential citation
• Germ-Line Mutanome Profiling of The Breast Cancers in Pakistani Population

  2018cites this paper
• Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

  2018cites this paper
• Estimating the age of the p.Cys433Arg variant in the MYOC gene in patients with primary open-angle glaucoma

  2018cites this paper
• A label-free electrochemical DNA sensor to identify breast cancer susceptibility

  2017cites this paper
• Detection of BRCA1 Founder Mutation 185DELAG in Breast Cancer Patients using Pyrosequencing Technique

  2017cites this paper
• Mutations in context: implications of BRCA testing in diverse populations

  2017cites this paper
• Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer

  2017cites this paper
• Genomic Disparities in Breast Cancer Among Latinas.

  2016cites this paper
• Haplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancer

  2016cites this paper
• Haplotype Analysis of BRCA 1 Gene D 17 S 855 and D 17 S 1322 Markers in Iranian Familial Breast Cancer Patients Sayed

  2016cites this paper
• Genetic diversity of disease-associated loci in Turkish population

  2015cites this paper
• VariantSpark: population scale clustering of genotype information

  2015cites this paper
• The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know.

  2015cites this paper
• Estimation of the RNU2 macrosatellite mutation rate by BRCA1 mutation tracing

  2014cites this paper
• Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history

  2014cites this paper
• Erratum to: Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history

  2014cites this paper
• For Peer Review The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.

  2013cites this paper
• The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.

  2013cites this paper
• Haplotype analysis and ancient origin of the BRCA1 c.4035delA Baltic founder mutation.

  2013cites this paper